With CD8 T-cells and TAMS being the key immune cells in the tumor microenvironment [18], [19], we analyzed if T cells and macrophage subtypes could be useful as a predictive marker to select mesothelioma patients for surgical treatment. Here, CD8A is linked to neoplasm.